Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy. [PDF]
Wong D, van Duin D.
europepmc +1 more source
Breaking Through Resistance: A Comparative Review of New Beta-Lactamase Inhibitors (Avibactam, Vaborbactam, Relebactam) Against Multidrug-Resistant Superbugs. [PDF]
Karaiskos I +3 more
europepmc +1 more source
A dataset for machine learning-based QSAR models establishment to screen beta-lactamase inhibitors using the FARM -BIOMOL chemical library. [PDF]
Pitakbut T +4 more
europepmc +1 more source
Point of care tests for hospital-acquired infections (HAIs) : economic analysis report [PDF]
A number of clinical/disease areas have been prioritised by the Technology Strategy Board (TSB) and Department of Health (DH) for the DIIA Innovation Platform.
Szczepura, Ala, Osipenko, Leeza
core
Utilizing machine learning-based QSAR model to overcome standalone consensus docking limitation in beta-lactamase inhibitors screening: a proof-of-concept study. [PDF]
Pitakbut T +4 more
europepmc +1 more source
Combatting resistant bacteria with the help of Beta-lactamase inhibitors. [PDF]
Abdel-Magid AF.
europepmc +1 more source
Plasmid-Mediated AmpC Detection in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>: In Vitro Prevalence and In Silico Inhibitor Design. [PDF]
Sarfraz M +9 more
europepmc +1 more source
<i>Escherichia coli</i> with penicillin-binding protein 3 insertions: implications for newer β-lactam/β-lactamase inhibitor combinations. [PDF]
Pitout JDD +4 more
europepmc +1 more source

